NCT06116903View on ClinicalTrials.gov

Clinical Relevance of Detecting Molecular Abnormalities in Glial Tumor Exosomes

NARecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

April 11, 2024

Primary Completion Date

May 15, 2025

Study Completion Date

December 15, 2025

Conditions
Glioma
Interventions
GENETIC

Blood sampling

Blood sampling for testing of the detection of molecular abnormalities in exosomes of glial tumors

Trial Locations (1)

87042

RECRUITING

CHU de Limoges, Limoges

All Listed Sponsors
lead

University Hospital, Limoges

OTHER